CD274 and cancer: High levels of PD-L1 expression in many malignancies have been linked to a bad prognosis [109], but they have also proven helpful in assisting physicians in determining whether patients with cancer are likely to benefit from ICI therapy, which has grown to be a significant treatment option for advanced cancer patients.